Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Dec;40(6):829-37.
doi: 10.1016/j.jpainsymman.2010.03.024. Epub 2010 Sep 17.

Family caregiver perspectives on symptoms and treatments for patients dying from complications of cystic fibrosis

Elisabeth P Dellon  1 , Mitchell D Shores, Katherine I Nelson, Joanne Wolfe, Terry L Noah, Laura C Hanson
Affiliations

Family caregiver perspectives on symptoms and treatments for patients dying from complications of cystic fibrosis

Elisabeth P Dellon et al. J Pain Symptom Manage. 2010 Dec.

Abstract

Context: Most patients with advanced cystic fibrosis (CF) die from respiratory failure and experience distressing symptoms as lung disease progresses. Little has been reported about symptom management and the continuation of disease-specific treatments near the end of life for patients with CF.

Objective: We aimed to describe symptom prevalence, symptom management, and frequency of use of disease-specific treatments for patients dying from complications of CF.

Methods: We conducted semistructured interviews about end-of-life care in CF with bereaved family caregivers and asked questions about symptoms and treatments.

Results: Twenty-seven caregivers answered questions about symptoms and treatments. Caregivers reported that distressing symptoms were common during the last week of life, including dyspnea (100%), fatigue (96%), anorexia (85%), anxiety (74%), pain (67%), and cough (56%). Most caregivers felt that symptom control was "somewhat good." Many reported that medical providers "did the best they could" to manage symptoms but four (15%) recalled no physician inquiry about symptoms. Caregivers expressed beliefs that symptoms could not be controlled and described concerns about side effects and potential for hastening death with the use of opioids and anxiolytics. Patients received numerous disease-specific treatments, and caregivers described many of them as uncomfortable but necessary.

Conclusions: Distressing symptoms are common in dying CF patients, and disease-specific treatments also cause discomfort. Many family caregivers have low expectations for symptom control. This exploratory research can be used to inform clinical interventions to improve symptom management for patients with advanced CF.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Disease-specific treatments used during last six months and last week of life.
Fig. 2
Fig. 2
Prevalence of symptoms and most distressing symptoms as reported by caregivers.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Cystic Fibrosis Foundation [Accessed March 2010];Patient registry: annual data report 2007. Available from http://www.cff.org/research/ClinicalResearch/PatientRegistryReport/
    1. Davis PB, di Sant’Agnese PA. Assisted ventilation for patients with cystic fibrosis. JAMA. 1978;239:1851–1854. - PubMed
    1. Egan TM, Murray S, Bistami RT, et al. Development of the new lung allocation system in the United States. Am J Transplant. 2006;6:1212–1227. - PubMed
    1. Gee L, Abbott J, Hart A, et al. Associations between clinical variables and quality of life in adults with cystic fibrosis. J Cyst Fibros. 2005;4:59–66. - PubMed
    1. Organ Procurement and Transplantation Network [Accessed March 2010];2009 Available from http://optn.transplant.hrsa.gov/

Publication types